Citations

Clear

400 citation(s) found for "Sm, Berry".

Automated Extraction of Microbial DNA From Formalin-Fixed, Paraffin-Embedded Tissue Using the Siemens Tissue Preparation System
Thorvilson, Jill N., Berry, Jonathan, Buckwalter, Seanne P., Lynne, Sloan, Rucinski, Stefanea L., Koelsch, Jolene M. , Pritt, Bobbi S. , Wengenack, Nancy L. , Pritt, Bobbi S , Saadalla, Abdulrahman , Schuetz, Audrey N.

Mayo Clinic

American Journal of Clinical Pathology | September 21, 2018 | Volume: 150 | Issue: suppl_1 | Pages: S151-S152

10.1093/ajcp/aqy112.357 Get It

An Academic Medical Center’s Learners’ Perceptions of Health Disparities
Greene, Eddie L., Quirindongo-Cedeño, Onelis, Weavers, Karen M. , Bock, Martha J. , Soto, Miguel Valdez , Cornelius, Katherine , Balls-Berry, Joyce E, Greene, Eddie, Weavers, Karen, Brockman, Tabetha A. , Bock, Martha, Patten, Christi A. , Enders, Felicity T, Balls‐Berry, Joyce E. , McCormick, Jennifer Blair , Enders, Felicity

Mayo Clinic

PRiMER | September 13, 2018 | Volume: 2 | Issue: No issue available | Pages: No page available

10.22454/primer.2018.867250 | PMID 32818191 Get It

Introduction: Lack of health equity ultimately leads to unequal treatment of diverse patients and contributes to the growing disparities seen in national health. Academic medical centers should consider providing health care providers and biomedical researchers training on how to identify and address health disparities. Methods: The authors led an introductory health disparities course for graduate students and research and clinical fellows at an academic medical center in the Midwest. We compared pre/postcourse assessments to determine changes in learners’ perceptions and knowledge of health disparities using an unpaired analysis to permit inclusion of responses provided only at baseline. Results: Sixty-two learners completed preassessment, with 56 completing the postassessment (90%). In the postcourse assessment, learners reported an increase in knowledge of disparities and had changes in their perceptions of health disparities linked to treatment of different patient groups based on demographic characteristics. There was a statistically significant difference in learners’ perceptions of how patients are treated based on gender identity (P=0.02) and sexual orientation (P=0.04). Conclusions: The results detail how an academic medical center can provide training on health disparities for diverse learners. This study underscores the influence of health disparities from the perspective of learners who conduct biomedical research and patient care. This course serves a model for introductory-level health disparities courses.
Pembrolizumab plus standard neoadjuvant therapy for high-risk breast cancer (BC): Results from I-SPY 2.
Nanda, Rita , Liu, Minetta C. , Asare, Smita , Hylton, Nola, Veer, Laura van’t, Perlmutter, Jane , Chien, A. Jo , Forero‐Torres, Andres , Ellis, Erin D. , Han, Heather, Clark, Amy S. , Albain, Kathy S. , Berry, Donald A. , Esserman, Laura, Yau, Christina , Wallace, Anne M. , Boughey, Judy C. , Elias, Anthony , Yee, Douglas , DeMichele, Angela

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 35 | Issue: 15_suppl | Pages: 506-506

10.1200/jco.2017.35.15_suppl.506 Get It

506 Background: Pembro is an anti-PD-1 antibody with single agent activity in HER2– metastatic BC. I-SPY 2 is a multicenter, phase 2 platform trial which evaluates novel neoadjuvant therapies; the primary endpoint is pathological complete response (pCR, ypT0/Tis ypN0). We report current efficacy results, with final results at ASCO. Methods: Patients (pts) with invasive BC ≥2.5 cm by exam or ≥2 cm by imaging are assigned weekly paclitaxel x 12 (control) +/- an experimental agent, followed by doxorubicin/cyclophosphamide x 4. Combinations of hormone-receptor (HR), HER2, & MammaPrint (MP) status define the 8 signatures studied. MP low HR+ BC is excluded. Adaptive randomization is based on each arm’s Bayesian probability of superiority over control. Graduation by signature is based on an arm’s Bayesian predictive probability of a successful 1:1 randomized phase 3 trial with a pCR endpoint. We provide raw & Bayesian estimated pCR rates adjusted for covariates, time effects over the course of the trial, & serial MRI modeling for pts not yet assessed for pCR surgically. Results: 69 pts were randomized to pembro (HER2- subsets only) from Dec 2015 until it graduated in Nov 2016. 46 pts have undergone surgery (table); the other 23 have on-therapy MRI assessments. In 29 HR–/HER2– (TNBC) pts, pembro increased raw & estimated pCR rates by >50% & 40%, respectively; in 40 HR+/HER– pts, it did so by 13% and 21%. 5 pts had immune-related grade 3 adverse events (AEs); 1 hypophysitis & 4 adrenal insufficiency. 4 pts presented after completion of AC (149-179 d after starting pembro); 1 presented prior to AC (37 d after starting pembro). 7 pts had grade 1-2 thyroid abnormalities. Conclusion: Pembro added to standard therapy improved pCR rates in all HER2- BCs that meet I-SPY 2 eligibility, especially in TNBC. Immune-mediated AEs were observed; pt follow up is ongoing. Clinical trial information: NCT01042379. [Table: see text]
Physiological and pathological high frequency oscillations in focal epilepsy
Cimbálník, Jan , Brinkmann, Benjamin H. , Křemen, Václav , Jurák, Pavel , Berry, Brent , Stead, Matt, Brinkmann, Benjamin, Brinkmann, Benjamin H , Kremen, Vaclav , Gompel, Jamie J. Van , Worrell, Gregory A.

Mayo Clinic

Annals of Clinical and Translational Neurology | August 10, 2018 | Volume: 5 | Issue: 9 | Pages: 1062-1076

10.1002/acn3.618 | PMID 30250863 Get It

Abstract Objective This study investigates high‐frequency oscillations ( HFO s; 65–600 Hz) as a biomarker of epileptogenic brain and explores three barriers to their clinical translation: (1) Distinguishing pathological HFO s (path HFO ) from physiological HFO s (phys HFO ). (2) Classifying tissue under individual electrodes as epileptogenic (3) Reproducing results across laboratories. Methods We recorded HFO s using intracranial EEG ( iEEG ) in 90 patients with focal epilepsy and 11 patients without epilepsy. In nine patients with epilepsy putative phys HFO s were induced by cognitive or motor tasks. HFO s were identified using validated detectors. A support vector machine ( SVM ) using HFO features was developed to classify tissue under individual electrodes as normal or epileptogenic. Results There was significant overlap in the amplitude, frequency, and duration distributions for spontaneous phys HFO , task induced phys HFO , and path HFO , but the amplitudes of the path HFO were higher ( P < 0.0001). High gamma path HFO had the strongest association with seizure onset zone ( SOZ ), and were elevated on SOZ electrodes in 70% of epilepsy patients ( P < 0.0001). Failure to resect tissue generating high gamma path HFO was associated with poor outcomes ( P < 0.0001). A SVM classified individual electrodes as epileptogenic with 63.9% sensitivity and 73.7% specificity using SOZ as the target. Interpretation A broader range of interictal path HFO (65–600 Hz) than previously recognized are biomarkers of epileptogenic brain, and are associated with SOZ and surgical outcome. Classification of HFO s into physiological or pathological remains challenging. Classification of tissue under individual electrodes was demonstrated to be feasible. The open source data and algorithms provide a resource for future studies.
Joint contracture is reduced by intra‐articular implantation of rosiglitazone‐loaded hydrogels in a rabbit model of arthrofibrosis
Arsoy, Diren , Salib, Christopher G. , Trousdale, William H. , Tibbo, Meagan E. , Limberg, Afton K. , Lewallen, Eric A. , Reina, Nicolas , Yaszemski, Michael J. , Berry, Daniel J., Wijnen, André J. van , Berry, Daniel J. , Viste, Anthony , Reina, Nicolas , Sanchez-Sotelo, Joaquin, van Wijnen, Andre J , Berry, Daniel J , Berry, Daniel J., Morrey, Mark E. , Sánchez‐Sotelo, Joaquín , Abdel, Matthew P.

Mayo Clinic

Journal of Orthopaedic Research | June 14, 2018 | Volume: 36 | Issue: 11 | Pages: 2949-2955

10.1002/jor.24068 | PMID 29901247 Get It

ABSTRACTTrauma, surgery, and other inflammatory conditions can lead to debilitating joint contractures. Adjunct pharmacologic modalities may permit clinical prevention and treatment of recalcitrant joint contractures. We investigated the therapeutic potential of rosiglitazone by intra‐articular delivery via oligo[poly(ethylene glycol)fumarate] (OPF) hydrogels in an established rabbit model of arthrofibrosis. OPF hydrogels loaded with rosiglitazone were characterized for drug elution properties upon soaking in minimum essential media (MEM) with 10% fetal bovine serum and measurements of drug concentrations via High Performance Liquid Chromatography (HPLC). Drug‐loaded scaffolds were surgically implanted into 24 skeletally mature female New Zealand White rabbits that were divided into equal groups receiving OPF hydrogels loaded with rosiglitazone (1.67 mg), or vehicle control (10 µl DMSO). After 8 weeks of joint immobilization, rabbits were allowed unrestricted cage activity for 16 weeks. Contracture angles of rabbit limbs treated with rosiglitazone showed statistically significant improvements in flexion compared to control animals (mean angles, respectively, 64.4° vs. 53.3°, p < 0.03). At time of sacrifice (week 24), animals in the rosiglitazone group continued to exhibit less joint contracture than controls (119.0° vs. 99.5°, p = 0.014). The intra‐articular delivery of rosiglitazone using implanted OPF hydrogels decreases flexion contractures in a rabbit model of arthrofibrosis without causing adverse effects (e.g., gross inflammation or arthritis). Statement of Clinical Significance: Post‐traumatic joint contractures are common and debilitating, with limited available treatment options. Pharmacologic interventions can potentially prevent and treat such contractures. This study is translational in that a commercially approved medication has been repurposed through a novel delivery device. © 2018 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 36:2949–2955, 2018.
Integrating artificial intelligence with real-time intracranial EEG monitoring to automate interictal identification of seizure onset zones in focal epilepsy
Varatharajah, Yogatheesan , Berry, Brent , Cimbálník, Jan , Křemen, Václav , Stead, Matt, Brinkmann, Benjamin H. , Van Gompel, Jamie, Brinkmann, Benjamin, Brinkmann, Benjamin H , Kremen, Vaclav , Gompel, Jamie J. Van , Iyer, Ravishankar K. , Worrell, Gregory A.

Mayo Clinic

Journal of Neural Engineering | June 1, 2018 | Volume: 15 | Issue: 4 | Pages: 046035

10.1088/1741-2552/aac960 | PMID 29855436 Get It

Abstract Objective . An ability to map seizure-generating brain tissue, i.e. the seizure onset zone (SOZ), without recording actual seizures could reduce the duration of invasive EEG monitoring for patients with drug-resistant epilepsy. A widely-adopted practice in the literature is to compare the incidence (events/time) of putative pathological electrophysiological biomarkers associated with epileptic brain tissue with the SOZ determined from spontaneous seizures recorded with intracranial EEG, primarily using a single biomarker. Clinical translation of the previous efforts suffers from their inability to generalize across multiple patients because of (a) the inter-patient variability and (b) the temporal variability in the epileptogenic activity. Approach . Here, we report an artificial intelligence-based approach for combining multiple interictal electrophysiological biomarkers and their temporal characteristics as a way of accounting for the above barriers and show that it can reliably identify seizure onset zones in a study cohort of 82 patients who underwent evaluation for drug-resistant epilepsy. Main results . Our investigation provides evidence that utilizing the complementary information provided by multiple electrophysiological biomarkers and their temporal characteristics can significantly improve the localization potential compared to previously published single-biomarker incidence-based approaches, resulting in an average area under ROC curve (AUC) value of 0.73 in a cohort of 82 patients. Our results also suggest that recording durations between 90 min and 2 h are sufficient to localize SOZs with accuracies that may prove clinically relevant. Significance . The successful validation of our approach on a large cohort of 82 patients warrants future investigation on the feasibility of utilizing intra-operative EEG monitoring and artificial intelligence to localize epileptogenic brain tissue. Broadly, our study demonstrates the use of artificial intelligence coupled with careful feature engineering in augmenting clinical decision making.
Arthroplasty implant registries over the past five decades: Development, current, and future impact
Garellick, Göran, Berry, Daniel J. , Harris, William H. , Robertson, Otto, Kärrlholm, Johan, Lewallen, David G. , Bragdon, Charles R. , Lidgren, Lars , Herberts, Peter, Berry, Daniel, Lewallen, David, Berry, Daniel J , Malchau, Henrik

Mayo Clinic

Journal of Orthopaedic Research | May 24, 2018 | Volume: 36 | Issue: 9 | Pages: 2319-2330

10.1002/jor.24014 | PMID 29663575 Get It

ABSTRACTLocal, regional, and national registries have played an important role in the development of hip and knee arthroplasty and the treatment of patients with various maladies of these joints. Four arthroplasty registries stand out as leading forces behind the drive to popularize the use of registries and pursue the concept of evidence based medicine. The Mayo registry, started by Mark Coventry, is recognized as the oldest continuing registry for arthroplasty. The Harris Registry at Massachusetts General Hospital, along with the Mayo Registry, has greatly contributed to the advancement of arthroplasty surgery and have served an important role of identifying poorly performing implants and techniques in the United States. The Swedish Knee Arthroplasty Registry is the oldest national registry dedicated to joint arthroplasty and along with the Swedish Hip Arthroplasty Registry have established the infrastructure, analysis and reporting mechanisms, and leadership that has enabled other countries to subsequently develop national registries around the world. As more countries have adopted the concept of national registries, a new area of research is possible by pooling the resources of large registries as is now occurring with the Nordic countries. Several international organizations have been formed to promote future collaboration and develop international standards. The process of globalization of registries is a result of continued efforts over the past 50 years in improving and disseminating the knowledge gained from the early registries. © 2018 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 36:2319–2330, 2018.
Biomarkers Associated with Progression of Diabetic Kidney Disease: Do They Hold the Same Meaning for Blacks and Women?
Hickson, LaTonya J. , Jaffe, Allan S. , Rule, Andrew D. , Rule, Andrew D , Hickson, LaTonya J , Balls‐Berry, Joyce E. , Jaffe, Allan S.

Mayo Clinic

Journal of the American Society of Nephrology | April 20, 2018 | Volume: 29 | Issue: 6 | Pages: 1781-1781

10.1681/asn.2017121249 | PMID 29678999 Get It